
New Parkinson's drug could slow or reverse progression of disease, researchers say: 'Big step forward'
Fox News
A new therapeutic that could slow down or halt the progression of Parkinson's disease has completed Phase 1 trials with positive results. Researchers and doctors spoke about the findings.
"Time and science will help us to determine if this newer approach will fare better." Angelica Stabile is a lifestyle writer for Fox News Digital.
Researchers conducted a phase 1 placebo-controlled trial of an investigational immunotherapy drug called UB-312, testing for safety, tolerability and immunogenicity (strength of immune response).
More Related News

Pizza before tomatoes? Ancient Rome's version of America's favorite food looked nothing like today's
Ancient Rome pizza at Hungary restaurant features no tomatoes or mozzarella, using garum fish sauce and olive paste. Neverland Pizzeria's dish is limited-edition.












